Metastatic involvement of the spleen by endometrial adenocarcioma; a rare asylum for a common malignancy: a case report by Adnan Arif et al.
Metastatic involvement of the spleen by
endometrial adenocarcioma; a rare asylum for a
common malignancy: a case report
Arif et al.
Arif et al. BMC Research Notes 2013, 6:476
http://www.biomedcentral.com/1756-0500/6/476
Arif et al. BMC Research Notes 2013, 6:476
http://www.biomedcentral.com/1756-0500/6/476CASE REPORT Open AccessMetastatic involvement of the spleen by
endometrial adenocarcioma; a rare asylum for a
common malignancy: a case report
Adnan Arif1, Zain Ul Abideen2*, Naeem Zia3, Muhammad Atif Khan1, Tariq Nawaz3 and Asif Zafar Malik3Abstract
Background: Metastatic involvement of the spleen by solid tumors is a rare clinical entity; those coming from
endometrial adenocarcinomas are exceptionally rare. Spleen is an uncommon site for metastatic deposits due to its
specific anatomy and microenvironment. Typically, splenic metastasis from endometrial carcinomas present months
to years after curative surgery, chemotherapy or radiotherapy. The most common complaint in symptomatic
patients is abdominal pain localized to the left hypochondrium. Most however, are asymptomatic only to be picked
up on vigilant routine ultrasonography or computerized tomography during follow up. We report the case of a
54-year-old woman who presented to us after 50 months of total abdominal hysterectomy and bilateral salpingo-
oophorectomy for an endometrial adenocarcinoma. She had severe abdominal pain localized to the left hypochondrium
as the presenting complaint. To the best of our knowledge, this is the 1st case to be reported from Pakistan with 14
cases reported prior to our report. All past cases report the endometroid variant of endometrial adenocarcinoma as the
primary tumor and our patient was a victim to the same variant.
Case presentation: A 54-year-old, nulliparous widowed woman presented with severe abdominal pain in the left
hypochondrium for the last 4 months. The pain radiated to the left shoulder and was exacerbated with deep breathing.
She had a history of total abdominal hysterectomy with bilateral salpingo-oophorectomy done 50 months back for
stage 1a endometroid endometrial adenocarcinoma. Clinical examination revealed tenderness in the left hypochondrium
but no visceromeglay was appreciable. Ultrasonography and computerized tomography revealed a space-occupying
lesion within the spleen with associated splenomegaly. Computed tomography further suggested a large splenic
abscess however the patient did not have fever, vomiting or leukocytosis which are the hallmarks of a splenic abscess.
A splenectomy was performed for her complaints. On histopathology a metastatic adenocarcinoma was identified
consistent with the primary tumor. The tumor was CK7, CA-125 and epithelial membrane antigen positive (EMA). The
patient was then referred for further chemotherapy.
Conclusion: From this case we conclude, that although very rare, the spleen is a potential site for metastasis in
endometroid endometrial adenocarcinoma. Since most patients are asymptomatic, routine examinations and imaging
can identify its presence and avoid complications. If the practice is employed with vigilance, we may expect the clinical
event to be diagnosed more frequently. The standard treatment is a classic splenectomy followed by chemotherapy.
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The spleen is a peculiar site for metastasis from solid tu-
mors; most commonly though, they are from breast, lung,
colorectal cancers and melanomas. The most cost com-
mon causes of solitary or isolated splenic metastasis are
colorectal and ovarian cancers. These deposits are usually
located on the splenic capsule and signify disseminated
disease with a grim prognosis [1]. Splenic metastasis from
endometrial carcinoma is considered exceptional; to date,
only 14 cases have been reported in the literature and this
is the 1st case to be reported from Pakistan. These deposits
are always solitary in the spleen, invade the parenchyma
only and metastasize via the haematogenous route. How-
ever, they do indicate a better prognosis [2]. They usually
present after a characteristic latent period; months to years
after curative surgery for the initial tumor. They may
present with painful splenomegaly or may be completely
asymptomatic only to be discovered on relevant imaging
during follow up. The cure accepted worldwide is a classic
splenectomy followed by post operative chemotherapy.
This case is accompanied by a brief review of the literature
to highlight important clinical aspects of the disease.
Case presentation
A 54-year-old, nulliparous and widowed house wife pre-
sented 4 years ago with post menopausal bleeding for
2 months duration. She underwent clinical evaluation and
was diagnosed as a case of endometroid adenocarcinomaFigure 1 Abdominal computed tomography showing the space occupof the endometrium; stage 1a and moderately well differ-
entiated. She underwent a total abdominal hysterectomy
and bilateral salpingo-oophorectomy. Histopathology con-
firmed the diagnosis, peritoneal washings for malignant
cells were negative and computed tomography (CT) scan
did not reveal any extra uterine spread of the tumor.
Histopathology of the ovaries and fallopian tubes was un-
remarkable as well. Fifty months later she presented with
severe abdominal pain in the left hypochondrium radiating
to the tip of the left shoulder for 4 months. The pain was
described as dull and dragging, aggravated by deep breath-
ing and occasionally relieved by analgesics; during the last
2 weeks she had multiple acute flare ups. On examination
her abdomen was tender in the left hypochondrium with-
out any palpable visceromegaly. Ultrasonography showed
an enlarged spleen with a space occupying lesion having
well defined walls in its lower part. This was clarified by
CT (Figures 1 and 2); the spleen measured 12×9×9 cm
with a splenic index of 931. A large heterogeneous well
defined lesion was seen in the spleen with peripheral en-
hancing and central necrosis. It measured about 9×9×8 cm.
A small exophytic component was also seen across the left
posterolateral wall. There was peri splenic fat stranding
with thickening of the Zukerkandl and lateral coronal
fascia. An opinion of splenic abscess was given by the radi-
ologist however the patient did not have the classic signs
of fever, vomiting and leukocytosis. All other investigations
including echocardiograms, blood and urine cultures wereying lesion inside the spleen (arrow).
Figure 2 Various views of the abdominal computed tomography showing the location of the space occupying lesion in the spleen (arrow).
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scess was isolated.
To alleviate patient symptoms a classic elective splen-
ectomy was performed. During the operation multiple
adhesions of the spleen with surrounding areas were
noted and an enlarged spleen containing a central nec-
rotic zone was extracted as shown in Figure 3. Figure 4
shows the histopathology of the gross specimen reveal-
ing a metastatic adenocarcinoma. Search for the pri-
mary in the gastrointestinal tract proved inconclusive.
The tumor was CA-125, CK-7 and epithelial membrane
antigen (EMA) positive. Vimentin, CK20, carcinoem-
bryonic antigen (CEA) and CDX2 were all negative. The
patient was discharged and referred for post-op chemo-
therapy. Her pain was relieved and she felt much better
on discharge.Figure 3 Gross specimen of the spleen after splenectomy.
A mass can be easily appreciated in the centre of the spleen
extending to the margins of the specimen; there is diffuse
infiltration of the parenchyma.Discussion
Solitary splenic metastasis is very uncommon and close
to 100 such cases have been reported in the literature
while those originating from endometrial adenocarcin-
oma are considered exceptional. Half of these are from
the female genital tract; most commonly from ovarian
malignancies (more than 30 cases) and the remainder
from endometrial (13 cases), cervical (6 cases) and tubal
carcinomas (1 case) [2].
Splenic metastasis are most commonly incidentally de-
tected by ultrasound (US) or CT during follow up or work
up of patients with cancer. When solitary, about 60% are
asymptomatic. Prominent symptoms at presentation in-
clude fatigue, weight loss, fever, and/or abdominal pain
while signs include splenomegaly with associated anemia
or thrombocytopenia while rarely presentation may be withFigure 4 Another view of the gross specimen clearly showing
no involvement of the splenic capsule which is characteristic
for endometroid endometrial adenocarcimona involvement of
the spleen.
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may be the first manifestation of recurrent solid cancers
in particular gynecologic malignancies [3]. A review had
shown 33% of solitary splenic metastasis were discovered
on routine examination while they were completely asymp-
tomatic [1]. Our patient only had a history of dull ab-
dominal pain which gradually increased in severity which
prompted the patient to seek emergency care.
US, CT and magnetic resonance imaging (MRI) are the
preferred diagnostic modalities while histopathology after
splenectomy confirms the type of tumor. La Fianza and
Madonia retrospectively compared US and CT in detection
of splenic metastasis after curative surgery; both provided
high accuracy, sensitivity and specificity however the micro-
nodular pattern of splenic involvement gave false positive
findings at US [4]. It is the prudent and regular use of these
imaging modalities during follow up that has increased the
number of case reports reported in the last decade. The
diagnosis in our patient was confirmed on histopathology
after splenectomy however the space occupying lesion and
splenomegaly were detected very accurately initially by US
and later by CT. Immunohistochemistry for endometroid
adenocarcinoma is also diagnostic; typically these tumors
are CK7, CA-125 positive and CK20 negative [5-7]. Our pa-
tient had a similar immunohistochemical profile. Splenic
metastasis have 3 major macroscopic patterns: macronodu-
lar, micronodular and diffuse [8]. The cancer lesions usually
affect the upper or lower pole, the hilum of the spleen and
rarely infiltrate the capsule [9]. Analysis of the post splenec-
tomy specimen of our patient revealed diffuse extensive in-
filtration of the parenchyma with involvement of the hilum
and lower pole and complete sparing of the capsule asFigure 5 Histopathology of the specimen. The black arrow shows the e
and nucleocytoplasmic ratio. There is formation of glands, nests and sheets
and the blue arrow shows the tumor – spleen parenchyma interface.shown in Figures 3 and 5. Capsular metastasis is usually
due to disseminated disease and commonly from breast,
ovarian or melanoma malignancies [1]. Usually, endomet-
rial carcinoma metastasizes after invasion of the myome-
trium and periuterine structures to neighboring lymph
nodes, liver, lungs, bones and other distal organs; distant
metastasis is often independent of the degree of differenti-
ation [10,11]. Splenic metastasis from endometrial carcin-
oma are usually solitary, located in the splenic parenchyma
and spread via the haematogenous route to the spleen.
Modes of spread from other malignancies include haemat-
gonous, lymphogenous, direct invasion or abdominal cavity
implantation. Solitary disease indicates a more indolent or
moderate progress of disease as was the case with our pa-
tient [2].
The stage of endometroid endometrial carcinoma in
our patient was 1 a and the tumor was moderately well
differentiated. The literature as such does not predict
any association between time of presentation and initial
stage of tumor. The past reports in the literature all re-
port the same histological type of the tumor.
An interesting fact about solitary splenic metastasis from
the endometrial adenocarcinoma is that they characteristic-
ally present after a period of clinical latency; the literature
describes 14 such cases with a range of presentation times
for relapse from 11 months to 120 months with a mean
time of 34.8 months. Our patient presented after 50 months
but started having symptoms at 46 months after surgery.
This phenomenon has been postulated to be due to growth
of early blood borne disseminated cancer cells within the
spleen [1]. Normally, the presence of splenic metastasis in
a patient with widespread disseminated disease carries nondometrial tissue comprising neoplastic glands, with increased mitosis
along with necrosis. The white arrow shows the normal splenic tissue
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splenic metstasis like in our patient points to a favorable
prognosis.
The relative rarity of metastatic involvement of the
spleen is speculated to be due to 2 reasons. Mechanical
factors including a constant flow of blood through the
sharply angulated splenic artery, rhythmic contractions
of the splenic capsule and the lack of afferent lymphatics
limiting lymphogenous metastasis all impede implant-
ation of blood borne cancer cells. Secondly; the splenic
microenvironment itself exerts an inhibitory influence to
growth of metastatic cells [3].
The treatment of choice is splenectomy; this not only al-
leviates the distressing painful splenomegaly like in our
patient but it also acts as a precaution against dreadful
complications like splenic rupture and splenic vein throm-
bosis. It also decreases chances of spread of the tumor to
distal areas from the spleen and provides the potential for
cure or extended survival [12].
After splenectomy our patient was completely pain
free; she was referred for chemotherapy and is currently
undergoing treatment.
Conclusion
In conclusion, although metastatic involvement of the
spleen from endometrial adenocarcinoma is rare, it is still
a potential site for disease asylum. The reported cases are
increasing due to advancements in imaging modalities and
more vigilant patient follow ups. Since the condition pre-
sents after a period of clinical latency after curative surgery
for the primary tumor and the patients remain asymptom-
atic until the tumor increases in size and creates complica-
tions, these patients need prolonged follow up with serial
imaging to identify recurrence. Once the lesion is diag-
nosed, splenectomy followed by adjuvant chemotherapy is
the treatment of choice.
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